C. Kohlsdorfer

500 total citations
9 papers, 429 citations indexed

About

C. Kohlsdorfer is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, C. Kohlsdorfer has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in C. Kohlsdorfer's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). C. Kohlsdorfer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). C. Kohlsdorfer collaborates with scholars based in Germany. C. Kohlsdorfer's co-authors include H M Siefert, Wolfram Steinke, Kerstin Henninger, Armin Witt, U. Pleiß, Ulf Buetehorn, Thomas Schwarz, Steffen Sandmann, Karl‐Heinz Schlemmer and Joachim Schuhmacher and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Pharmaceutical Sciences.

In The Last Decade

C. Kohlsdorfer

9 papers receiving 418 citations

Peers

C. Kohlsdorfer

PHARM

CCM

EPIDE

MB

IM

Markus Mueller Austria

Mark Lovern United States

Johannes Nagelschmitz Germany

U. Ganzinger Austria

Satoshi Kishino Japan

William Knebel United States

Xiaoshan Zhang China

Yoshiaki Ikeda Japan

Nicholas Farinola Australia

Mirjam N. Trame United States

Markus Mueller Austria

C. Kohlsdorfer

162 ×1.0

PHARM

20 ×0.2

CCM

98 ×1.1

EPIDE

71 ×1.0

MB

10 ×0.2

IM

Citations per year, relative to C. Kohlsdorfer C. Kohlsdorfer (= 1×) peers Markus Mueller

Countries citing papers authored by C. Kohlsdorfer

Since Specialization

Citations

This map shows the geographic impact of C. Kohlsdorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kohlsdorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kohlsdorfer more than expected).

Fields of papers citing papers by C. Kohlsdorfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kohlsdorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kohlsdorfer. The network helps show where C. Kohlsdorfer may publish in the future.

Co-authorship network of co-authors of C. Kohlsdorfer

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kohlsdorfer. A scholar is included among the top collaborators of C. Kohlsdorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kohlsdorfer. C. Kohlsdorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Heinig, Roland, Carsten Schmeck, C. Kohlsdorfer, et al.. (2011). Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60–5521, a potent inhibitor of cholesteryl ester transfer protein. British Journal of Clinical Pharmacology. 73(2). 210–218. 16 indexed citations

2.

Buetehorn, Ulf, C. Kohlsdorfer, U. Pleiß, et al.. (2005). Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs. Xenobiotica. 35(9). 891–910. 86 indexed citations

3.

Schuhmacher, Joachim, et al.. (2004). High-throughput determination of the free fraction of drugs strongly bound to plasma proteins. Journal of Pharmaceutical Sciences. 93(4). 816–830. 40 indexed citations

4.

Siefert, H M, et al.. (1999). Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. Journal of Antimicrobial Chemotherapy. 43(suppl_2). 69–76. 124 indexed citations

5.

Siefert, H M, C. Kohlsdorfer, Wolfram Steinke, & Armin Witt. (1999). Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy. 43(suppl_2). 61–67. 62 indexed citations

6.

Schmidt, Holger, A. Dalhoff, K. Stuertz, et al.. (1998). Moxifloxacin in the Therapy of Experimental Pneumococcal Meningitis. Antimicrobial Agents and Chemotherapy. 42(6). 1397–1401. 49 indexed citations

7.

Fugmann, Burkhard, Phillip J. Gardiner, Bodo Junge, et al.. (1995). Leukotriene Synthesis Inhibitors of the Quinoline Type: Parameters for the Optimization of Efficacy. European Journal of Medicinal Chemistry. 30. 441s–451s. 7 indexed citations

8.

Müller‐Peddinghaus, R., et al.. (1993). BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 51–57. 32 indexed citations

9.

Müller‐Peddinghaus, R., Bernhard Beckermann, Burkhard Fugmann, et al.. (1993). BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics.. PubMed. 6(1-3). 245–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact